Crossmark

Ultrasound imaging in rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1007/s11547-019-01002-2

Published Online: 2019-03-09

Published Print: 2019-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Filippucci, Emilio https://orcid.org/0000-0002-7251-7784
Cipolletta, Edoardo https://orcid.org/0000-0002-6881-8197
Mashadi Mirza, Riccardo

Carotti, Marina https://orcid.org/0000-0001-6562-180X
Giovagnoni, Andrea https://orcid.org/0000-0002-5264-652X
Salaffi, Fausto https://orcid.org/0000-0002-3794-6831
Tardella, Marika

Di Matteo, Andrea

Di Carlo, Marco https://orcid.org/0000-0002-0906-4647
License Information

Text and Data Mining valid from 2019-03-09
More Information

Article History

Received: 14 January 2019

Accepted: 4 February 2019

First Online: 9 March 2019

Compliance with ethical standards

:

: E.F. has received personal fees from AbbVie, Bristol-Myers Squibb, Celgene, Roche and UCB Pharma. R.M.M has received personal fees from Bracco. A.D.M has received personal fees from Grunenthal. M.D.C. reports personal fees from AbbVie and Novartis. All other authors have declared no conflicts of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.